← FDA DRUG APPROVALS

FDA NDA · NDA021456

ACIPHEX

Sponsor: EISAI MEDCL RES

APPLICATION
NDA021456
TYPE
NDA
ORIGINAL APPROVAL
2002-11-08
LATEST ACTION
2002-11-08
ROUTE
Oral
DOSAGE FORM
Tablet, Delayed Release
MARKETING STATUS
Prescription

Products

ACIPHEXPrescription
RABEPRAZOLE SODIUM 20MG · Tablet, Delayed Release · Oral

Approval history

2002-11-08Type 6 - New Indication (no longer used) · Original · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →